Publikation

Angiogenesis in liver disease

Wissenschaftlicher Artikel/Review - 31.12.2008

Bereiche
PubMed
DOI

Zitation
Fernández M, Semela D, Bruix J, Colle I, Pinzani M, Bosch J. Angiogenesis in liver disease. J Hepatol 2008; 50:604-20.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
J Hepatol 2008; 50
Veröffentlichungsdatum
31.12.2008
ISSN (Druck)
0168-8278
Seiten
604-20
Kurzbeschreibung/Zielsetzung

Angiogenesis and disruption of liver vascular architecture have been linked to progression to cirrhosis and liver cancer (HCC) in chronic liver diseases, which contributes both to increased hepatic vascular resistance and portal hypertension and to decreased hepatocyte perfusion. On the other hand, recent evidence shows that angiogenesis modulates the formation of portal-systemic collaterals and the increased splanchnic blood flow which are involved in the life threatening complications of cirrhosis. Finally, angiogenesis plays a key role in the growth of tumours, suggesting that interference with angiogenesis may prevent or delay the development of HCC. This review summarizes current knowledge on the molecular mechanisms of liver angiogenesis and on the consequences of angiogenesis in chronic liver disease. On the other hand, it presents the different strategies that have been used in experimental models to counteract excessive angiogenesis and its potential role in preventing transition to cirrhosis, development of portal hypertension and its consequences, and its application in the treatment of hepatocellular carcinoma.